Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123101) titled 'Prospective, Multicenter, Randomized Phase III Clinical Trial of Maintenance Immunotherapy With or Without Radiotherapy After First-Line Immunochemotherapy in Advanced Oligometastatic NSCLC' on April 21.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Chinese Academy of Medical Sciences Cancer Hospital
Condition:
Oligometastatic non-small cell lung cancer with negative driver genes
Intervention:
Experimental group:Maintenance immunotherapy and radiotherapy to the primary and/or oligometastatic lesions
Recruitment Status: Not Recruiting
Phase: 3
Date of First Enrollment: 2026-05-...